Axsome Therapeutics NasdaqGM:AXSM Stock Report ; Last Price. US$ ; Market Cap. US$b ; 7D. % ; 1Y. % ; Updated. 30 Aug, View the latest Axsome Therapeutics Inc. (AXSM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover real-time Axsome Therapeutics, Inc. Common Stock (AXSM) stock prices, quotes, historical data, news, and Insights for informed trading and. What is the forecast, or price target, for Axsome Therapeutics (AXSM) stock? A. Axsome Therapeutics has a consensus price target of $ Q. What is the. Track Axsome Therapeutics Inc (AXSM) Stock Price, Quote, latest community messages, chart, news and other stock related information.
Latest news: Axsome Therapeutics, Inc. · Axsome Therapeutics Reaches Agreement to Dismiss Sunosi Patent Litigation With Sandoz · Axsome Therapeutics Insider Sold. news. Barron's. Other Dow Jones. Press Releases. Aug. 19, p.m. ET. Fast-Acting Depression Drug Wins FDA Approval. Axsome Stock Is Flying. June Axsome focuses on CNS conditions including depression, Alzheimer's disease agitation, migraine, narcolepsy and fibromyalgia. Axsome Therapeutics Inc News & Analysis · Morgan Stanley maintains price target, overweight rating on Axsome shares · BofA sees strong upside for Axsome stock. Axsome Therapeutics, Inc. (NASDAQ:AXSM - Get Free Report) COO Mark L. Jacobson sold 47, shares of the company's stock in a transaction dated Friday, August. The current price of AXSM is USD — it has decreased by −% in the past 24 hours. Watch Axsome Therapeutics, Inc. stock price performance more closely. Get Axsome Therapeutics Inc (AXSM.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. On average, Wall Street analysts predict that Axsome Therapeutics's share price could reach $ by Aug 22, The average Axsome Therapeutics stock price. Ratings · Express News | Axsome Therapeutics, Inc.: Wells Fargo Initiates Coverage With Overweight Rating and Target Price $ · Axsome Therapeutics to. Axsome Therapeutics Stock Smart Score ; Analyst Consensus. Strong Buy. Average Price Target: $ (% Upside) ; Blogger Sentiment. Bullish. AXSM Sentiment. Axsome Therapeutics, Inc. (NASDAQ: AXSM) is a leading biopharmaceutical company dedicated to developing innovative therapies for the treatment of central.
Ardelyx Inc. $ ARDX % ; TG Therapeutics Inc common stock. $ TGTX % ; Nkarta Inc. $ NKTX % ; DURECT Corp. $ DRRX % ; Upstart. 33 minutes ago. Axsome: Revenue Surges, Net Loss Widens. Axsome Therapeutics posted strong revenue growth, but faced rising operational losses and costs. JesterAI | Aug 5. News for Axsome Therapeutics Stock (AXSM) ; Will Axsome Stock Rebound After A 19% Fall In A Month? · 07/23/21 ; Axsome (AXSM) Falls 10% After Losing Breakthrough. Axsome's stock rallies 15% on promising findings for its experimental Alzheimer's drug. Shares of Axsome Therapeutics Inc. jumped % in premarket trading on. Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central. Axsome Therapeutics Inc AXSM:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/12/24 · 52 Week Low. In the current month, AXSM has received 31 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AXSM average Analyst price target in the past 3 months is $ Latest Press Releases · Axsome Therapeutics to Participate in Investor Conferences in September · Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® .
Axsome Therapeutics Inc. ; Prev. Close. ; Low. ; 52wk Low. ; Market Cap. b ; Total Shares. m. Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps % this past week. When you buy shares in a company, it's worth keeping. Axsome Therapeutics (AXSM) reported Q2 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Axsome. View Axsome Therapeutics (AXSM) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. A high-level overview of Axsome Therapeutics, Inc. (AXSM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and.
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United. View the latest Axsome Therapeutics Inc. (AXSM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Axsome Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AXSM. The last closing price for Axsome Therapeutics was. Get the latest news and real-time alerts from Axsome Therapeutics, Inc. (AXSM) stock at Seeking Alpha. See the latest Axsome Therapeutics Inc stock price (AXSM:XNAS), related news, valuation, dividends and more to help you make your investing decisions.